HIV & AIDS

A better understanding of how HIV-1 evades the immune system

The type of virus used as a model to study the efficacy of non-neutralizing antibodies against the virus responsible for AIDS has a crucial role to play, according to a new study led by Andrés Finzi, Université de Montréal ...

Diseases, Conditions, Syndromes

New Lassa fever therapy may be on the horizon

A new study from scientists at La Jolla Institute for Immunology (LJI) gives researchers a guide to neutralizing Lassa virus using a trio of rare antibodies isolated from survivors of Lassa virus infection.

Diseases, Conditions, Syndromes

Researchers discover 'weak spot' across major COVID-19 variants

Researchers at the University of British Columbia have discovered a key vulnerability across all major variants of the SARS-CoV-2 virus, including the recently emerged BA.1 and BA.2 Omicron subvariants.

Diseases, Conditions, Syndromes

Powerful new antibody neutralizes all known SARS-CoV-2 variants

As SARS-CoV-2 has evolved and mutated, therapeutic antibodies that worked early in the pandemic have become less effective, and newer variants, especially omicron, have developed ways to evade the antibodies we make in response ...

page 5 from 35